Clinicopathological progress of dual-phenotype hepatocellular carcinoma

Clinicopathological progress of dual-phenotype hepatocellular carcinoma (DPHCC) is a new subtype of hepatocellular carcinoma with poor prognosis. Immunohistochemistry plays a key role in the diagnosis of DPHCC. DPHCC is closely related to the mechanism of epithelial-mesenchymal transition and the st...

Full description

Bibliographic Details
Main Authors: Lei Li, Guangjie Liao
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Annals of Oncology Research and Therapy
Subjects:
Online Access:http://www.aort.info/article.asp?issn=2772-8382;year=2023;volume=3;issue=1;spage=6;epage=13;aulast=Li
_version_ 1797225820536700928
author Lei Li
Guangjie Liao
author_facet Lei Li
Guangjie Liao
author_sort Lei Li
collection DOAJ
description Clinicopathological progress of dual-phenotype hepatocellular carcinoma (DPHCC) is a new subtype of hepatocellular carcinoma with poor prognosis. Immunohistochemistry plays a key role in the diagnosis of DPHCC. DPHCC is closely related to the mechanism of epithelial-mesenchymal transition and the stem cell characteristics of tumors. At present, there were few relevant literatures. We review the clinicopathological progress of DPHCC.
first_indexed 2024-03-07T21:36:31Z
format Article
id doaj.art-593846ddf6d74f26b0a2c90735e1c1c6
institution Directory Open Access Journal
issn 2772-8382
2772-8390
language English
last_indexed 2024-04-24T14:15:05Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Annals of Oncology Research and Therapy
spelling doaj.art-593846ddf6d74f26b0a2c90735e1c1c62024-04-03T08:46:57ZengWolters Kluwer Medknow PublicationsAnnals of Oncology Research and Therapy2772-83822772-83902023-01-013161310.4103/aort.aort_32_22Clinicopathological progress of dual-phenotype hepatocellular carcinomaLei LiGuangjie LiaoClinicopathological progress of dual-phenotype hepatocellular carcinoma (DPHCC) is a new subtype of hepatocellular carcinoma with poor prognosis. Immunohistochemistry plays a key role in the diagnosis of DPHCC. DPHCC is closely related to the mechanism of epithelial-mesenchymal transition and the stem cell characteristics of tumors. At present, there were few relevant literatures. We review the clinicopathological progress of DPHCC.http://www.aort.info/article.asp?issn=2772-8382;year=2023;volume=3;issue=1;spage=6;epage=13;aulast=Lidual-phenotype hepatocellular carcinomaclinicopathologyimmunohistochemistryresearch progress
spellingShingle Lei Li
Guangjie Liao
Clinicopathological progress of dual-phenotype hepatocellular carcinoma
Annals of Oncology Research and Therapy
dual-phenotype hepatocellular carcinoma
clinicopathology
immunohistochemistry
research progress
title Clinicopathological progress of dual-phenotype hepatocellular carcinoma
title_full Clinicopathological progress of dual-phenotype hepatocellular carcinoma
title_fullStr Clinicopathological progress of dual-phenotype hepatocellular carcinoma
title_full_unstemmed Clinicopathological progress of dual-phenotype hepatocellular carcinoma
title_short Clinicopathological progress of dual-phenotype hepatocellular carcinoma
title_sort clinicopathological progress of dual phenotype hepatocellular carcinoma
topic dual-phenotype hepatocellular carcinoma
clinicopathology
immunohistochemistry
research progress
url http://www.aort.info/article.asp?issn=2772-8382;year=2023;volume=3;issue=1;spage=6;epage=13;aulast=Li
work_keys_str_mv AT leili clinicopathologicalprogressofdualphenotypehepatocellularcarcinoma
AT guangjieliao clinicopathologicalprogressofdualphenotypehepatocellularcarcinoma